Core I - More than 90 percent of the global HIV burden falls outside of the United States: 70 percent in Sub-Saharan Africa, 14 percent in Asia and the Pacific, 5 percent in Latin America and the Caribbean, and 4 percent in Eastern Europe and Central Asia. The majority of these regions comprise low- and middle-income countries (LMIC), which lack both scientific and clinical resources to treat existing HIV infections and prevent new ones. Mozambique, for example, has 0.055 doctors per 1000 persons; Zimbabwe, 0.074; India, 0.725; and Brazil, 1.852. The International Core (IC) of the San Diego (SD) CFAR addresses these discrepancies by serving as a resource hub for foreign research supported by our Center. Our local investigators guide foreign scientists in writing pilot grant proposals, designing studies, and analyzing data. Our Co-Directors and administrative team explain NIH regulatory and funding requirements. We provide similar assistance as well as valuable foreign connections for local SD CFAR researchers who wish to pursue international HIV research. Thus we encourage emerging investigators to gain independence and pursue their own funding. Simultaneously, we add value to the SD CFAR by fostering long-term collaborations between local and foreign investigators, which leads to subsequent peer-reviewed publications and grant funding. We also refer our local and international investigators to other Cores for specialized services that will benefit their SD CFAR-funded projects. International projects often take longer than domestic studies to generate a return on investment, so we emphasize productivity since the Core was initiated. From 2007 to date, we have supported a total of 63 studies that have resulted in 81 papers and $42.7 million in subsequent funding (ROI $25). Over the next 5 years, the IC will expand and improve its services through the following 4 units, each having specific responsibilities in service to the SD CFAR and the international HIV research community: Evaluation Unit?To ensure applications for International Pilot grants contribute to the high-impact science associated with the SD CFAR; Regulatory Unit?Ensure research projects recommended by the Evaluation Unit and the Developmental Core Grant Review Committee meet NIH and local regulatory standards; Communications Unit?Expedite application and review processes, and apply, clarify, or update policies; Training and Mentoring Unit?Implement administrative and technical training for foreign investigators and ensure that domestic and international investigators receive in-depth mentoring as needed from senior SD CFAR members and International Core Co-Directors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI036214-24
Application #
9537795
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
24
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Heldt, Sven; Prattes, Juergen; Eigl, Susanne et al. (2018) Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples. J Infect 77:235-241
Garfein, Richard S; Liu, Lin; Cuevas-Mota, Jazmine et al. (2018) Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA. Emerg Infect Dis 24:1806-1815
Canan, Chelsea E; Chander, Geetanjali; Monroe, Anne K et al. (2018) High-Risk Prescription Opioid Use Among People Living With HIV. J Acquir Immune Defic Syndr 78:283-290
Jenks, Jeffrey Daniel; Hoenigl, Martin (2018) CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy. J Lab Precis Med 3:
White, Cory H; Beliakova-Bethell, Nadejda; Lada, Steven M et al. (2018) Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment. Front Immunol 9:603
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Gianella, Sara; Marconi, Vincent C; Berzins, Baiba et al. (2018) Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. J Acquir Immune Defic Syndr 79:e112-e114
Innes, Steve; Patel, Kunjal (2018) Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings. Curr Opin HIV AIDS 13:187-195
Morales, Mario; Rafful, Claudia; Gaines, Tommi L et al. (2018) Factors associated with extrajudicial arrest for syringe possession: results of a department-wide survey of municipal police in Tijuana, Mexico. BMC Int Health Hum Rights 18:36
Rhodes, Tim (2018) The becoming of methadone in Kenya: How an intervention's implementation constitutes recovery potential. Soc Sci Med 201:71-79

Showing the most recent 10 out of 921 publications